Age-independent first trimester screening for Down syndrome: Analysis of three modified software programs with 6,508 pregnancies

Archives of Gynecology and Obstetrics

Volumn 283, Issue 4, 2011, Pages 749-754

  Hormansdorfer C ^a   Golatta, M ^b   Scharf, A ^b   Hillemanns, P ^a   Schmidt, P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aneuploidy; Down syndrome; First trimester; Maternal age; Trisomy 21

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC TEST ACCURACY STUDY; DOWN SYNDROME; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; INTERMETHOD COMPARISON; JOY SOFTWARE; MATERNAL AGE; PIA FETAL DATABASE; PRENATAL RISK CALCULATION; PRENATAL SCREENING; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; DOWN SYNDROME; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; MATERNAL AGE; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, FIRST; ROC CURVE; SENSITIVITY AND SPECIFICITY; SOFTWARE; YOUNG ADULT;

EID: 79955934064     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-010-1452-y     Document Type: Article

References (18)

1. Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH (1999) Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 13(3):167-170 (Pubitemid 29176889)
2. Spencer K, Souter V, Tul N, Snijders RJM, Nicolaides KH (1999) A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13:231-237 (Pubitemid 29248329)
3. Schmidt P, Pruggmayer M, Steinborn A, Schippert C, Staboulidou I, Hillemanns P, Scharf A (2007) Are nuchal translucency, pregnancy associated plasma protein-A or free-β-human chorionic gonadotropin depending on maternal age? A multicenter study of 8116 pregnancies. Arch Gynecol Obstet 276(3):259-262 (Pubitemid 47125091)
4. Schmidt P, Hörmansdörfer C, Pruggmayer M, Schütte C, Neumann A, Gerritzen A, Vaske B, Hillemanns P, Scharf A (2008) Improved prenatal aneuploidy screening using the novel advanced first-trimester screening algorithm: a multicenter study of 10, 017 pregnancies. J Clin Ultrasound 36(7):397-402
5. Gebb J, Dar P (2009) Should the first-trimester aneuploidy screen be maternal age adjusted? Screening by absolute risk versus risk adjusted to maternal age. Prenat Diagn 29:245-247
6. Hörmansdörfer C, Schmidt P, Hillemanns P, Scharf A (2007) Die pränatale Detektion der Trisomien 13, 18 und 21: Vergleich des advanced first trimester screenings (AFS)® mit dem Ersttrimester-Screening nach Nicolaides. Z Geburtshilfe Neonatol 211(6):243-249
7. Schmidt P, Hörmansdörfer C, Oehler K, Hertel H, Hillemanns P, Scharf A (2008) Dreidimensionale Scatterplotanalyse zur Risikoeinschätzung für fetale Aneuploidien: Eine Weiterentwicklung des Ersttrimester Screenings. Z Geburtshilfe Neonatol 212:127-135
8. Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, Porter TF, Luthy DA, Comstock CH, Saade GR, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME (2006) Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 108(5):1067-1072 (Pubitemid 44665399)
9. Bieniakiewicz I, Brunk J, Lammers C, Gembruch U, Kowalcek I (2006) Die aktuelle Beanspruchung werdender Eltern vor und nach pränataler Diagnostik in Abhängigkeit von der Untersuchungsindikation. Geburtsh Frauenheilk 66:566-574 (Pubitemid 44185457)
10. Schmidt P, Hörmansdörfer C, Staboulidou I, Seydel J, Vaske B, Brocker K, Hillemanns P (2008) Gesundheitsökonomische Aspekte des Downsyndrom-Screenings: Vergleich zweier Risikokalkulationsprogramme mit den derzeitigen Bestimmungen der Mutterschaftsrichtlinien in Deutschland. Geburtsh Frauenheilk 68:69-76
11. Nicolaides KH, Heath V, Cicero S (2002) Increased fetal nuchal translucency at 11-14 weeks. Prenat Diag 22:308-315 (Pubitemid 34498767)
12. Palomaki GE, Haddow JE (1987) Maternal serum alpha-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol 156(2):460-463 (Pubitemid 17020516)
13. Schetinin V, Fieldsend JE, Partridge D, Coats TJ, Krzanowski WJ, Everson RM, Bailey TC, Hernandez A (2007) Confident interpretation of Bayesian decision tree ensembles for clinical applications. IEEE Trans Inf Technol Biomed 11(3):312-319 (Pubitemid 46746181)
14. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH (1998) UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 351:343-346 (Pubitemid 28352196)
15. Merz E, Thode C, Alkier A, Eiben B, Hackelöer BJ, Hansmann M, Huesgen G, Kozlowski P, Pruggmaier M, Wellek S (2008) A new approach to calculating the risk of chromosomal abnormalities with first-trimester screening data. Ultraschall Med 29(6):639-645
16. Wald NJ, Hackshaw AK (1997) Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 17(9):821-829 (Pubitemid 27384797)
17. Schmidt P, Staboulidou I, Soergel P, Wüstemann M, Hillemanns P, Scharf A (2007) Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1463 cases. Arch Gynecol Obstet 275:469-474 (Pubitemid 46798913)
18. Mansfield C, Hopfer S, Marteau TM (1999) Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (decision-making after the diagnosis of a fetal abnormality). Prenat Diagn 19(9):808-812 (Pubitemid 29438168)